NCT05319925View on ClinicalTrials.gov

Financial Effects of a Tumor Disease - Development and Validation of a Patient Reported Outcome Measure in Germany

CompletedOBSERVATIONAL
Enrollment

213

Participants

Timeline

Start Date

June 1, 2022

Primary Completion Date

July 31, 2023

Study Completion Date

July 31, 2023

Conditions
Cancer
Interventions
OTHER

Patient reported outcome measure

Newly developed patient-reported instrument to measure financial effects of a cancer diagnosis and therapy of cancer patients in Germany

Trial Locations (1)

Unknown

National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg

All Listed Sponsors
collaborator

Chair of Methods in Empirical Social Research, Institute of Sociology, Technische Universität Dresden

UNKNOWN

collaborator

Health Economics and Health Care Management, Bielefeld University

UNKNOWN

collaborator

Haematology and Oncology, University of Jena

UNKNOWN

lead

University Hospital Heidelberg

OTHER